AstraZeneca's Breakout in the Healthcare Industry

AstraZeneca has been working from its own cup of handle at around 60 to 74 roughly 63 dollars was the proper buy point and the stock has gained uh not quite 20 percent yet. Unlike ALKS a mid-cap company with about a five billion market cap this is a mega cap in the healthcare field 187 billion dollars in market value 2.8 billion shares in float so it would take a tremendous amount of buying or selling to send the stock in either direction that direction is up 92 relative strength rating RS line is at a new in new high ground according to the market Smith Blue dot RS line screenCompany has really strong earnings growth estimates going forward including a 34 percent increase for this year three